Poland: Amendment to the new Reimbursement Act

In brief

Recently, the Polish Minister of Health ("MoH") has resumed work on the largest amendment to the Polish Act on Reimbursement ("Draft") since its introduction into the Polish legal system in 2012. Although during almost eleven years of this Act being in force some areas requiring amendments have been identified, the Draft is all about something different.


Contents

Key takeaways

The initial version of the Draft was published for public consultation by the MoH on 30 June 2021.

Analysis of the comments submitted within the public consultations took a long time as the MoH only sent the new version of the Draft to the Permanent Committee of the Council of Ministers on 26 August 2022. This means that work on the Draft has now resumed, although the expectation of the pharmaceutical industry was that the MoH would discontinue them.

The resumption of work is all the more problematic as the MoH has chosen to leave in place most of the unfavorable proposals that have been criticized by the industry. If adopted in its current shape, there are concerns that the new regulations would be detrimental to the Polish reimbursement system as a whole. It would hit hard particularly on oncology and rare disease drugs by introducing solutions, summarized in this newsletter, setting up real barriers for their reimbursement in the future.

Below please see a brief summary of the most important amendments proposed by the MoH.

Click here to access the full alert.


Copyright © 2024 Baker & McKenzie. All rights reserved. Ownership: This documentation and content (Content) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms). The Content is protected under international copyright conventions. Use of this Content does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All Content is for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulations and practice are subject to change. The Content is not offered as legal or professional advice for any specific matter. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any Content. Baker McKenzie and the editors and the contributing authors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The Content may contain links to external websites and external websites may link to the Content. Baker McKenzie is not responsible for the content or operation of any such external sites and disclaims all liability, howsoever occurring, in respect of the content or operation of any such external websites. Attorney Advertising: This Content may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Content may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. Reproduction: Reproduction of reasonable portions of the Content is permitted provided that (i) such reproductions are made available free of charge and for non-commercial purposes, (ii) such reproductions are properly attributed to Baker McKenzie, (iii) the portion of the Content being reproduced is not altered or made available in a manner that modifies the Content or presents the Content being reproduced in a false light and (iv) notice is made to the disclaimers included on the Content. The permission to re-copy does not allow for incorporation of any substantial portion of the Content in any work or publication, whether in hard copy, electronic or any other form or for commercial purposes.